Skip to Content
Return to Navigation

Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune Response – Bloomberg, 5/18

An experimental vaccine from the U.S. biotechnology company Moderna Inc. showed signs that it can create an immune-system response to fend off the new coronavirus, offering tentative hopes in the global effort to combat the pandemic. The results are just a sample from the small, first study designed to look at the safety of the shot in human volunteers, and should be viewed with caution. But they showed no major safety worries, a key first hurdle since a vaccine would be given to millions of otherwise healthy people. РBloomberg, 5/18/2020

Share this article: